Sign In
Buy SNY
$43.98
-0.680 (-1.52%)
At Close: Jul 20, 2026
Sanofi Stock Drops After Confirming Raid, Tax Fraud Investigation
11:05am, Wednesday, 26'th Nov 2025
Sanofi stock dropped Wednesday after French authorities raided the drugmaker's Paris headquarters as part of a tax fraud investigation.
Sanofi (NASDAQ:SNY) Given Consensus Rating of “Buy” by Analysts
04:24am, Wednesday, 26'th Nov 2025
Shares of Sanofi (NASDAQ: SNY - Get Free Report) have received an average recommendation of "Buy" from the eleven analysts that are currently covering the firm, MarketBeat Ratings reports. Two researc
Sanofi $SNY Shares Bought by American Century Companies Inc.
03:05am, Wednesday, 26'th Nov 2025
American Century Companies Inc. lifted its stake in shares of Sanofi (NASDAQ: SNY) by 29.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commiss
Sanofi Faces Surprise HQ Search As French Authorities Expand Tax Probe
01:30pm, Tuesday, 25'th Nov 2025
Sanofi SA's (NASDAQ: SNY) Paris headquarters received an unannounced visit on Tuesday as tax investigators, accompanied by prosecutors and specialist aides, searched the site amid a widening financial
SNY & REGN's Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
11:46am, Tuesday, 25'th Nov 2025
Sanofi/Regeneron's Dupixent wins EU nod for chronic spontaneous urticaria, marking its seventh approved indication across inflammatory diseases in the EU.
Aviso Financial Inc. Grows Stock Holdings in Sanofi $SNY
03:32am, Tuesday, 25'th Nov 2025
Aviso Financial Inc. boosted its holdings in shares of Sanofi (NASDAQ: SNY) by 4.3% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). Th
Sanofi and Regeneron's Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Bristol Myers, Sanofi sued by Texas over Plavix
04:06pm, Thursday, 20'th Nov 2025
Texas Attorney General Ken Paxton sued Bristol Myers Squibb and Sanofi , accusing the drugmakers of failing to disclose that Plavix, which is used to prevent blood clots, does not work effectively for
Lifordi Immunotherapeutics Secures Strategic Investment from Sanofi Ventures and Additional Capital from Existing Investors
12:20pm, Tuesday, 18'th Nov 2025
Burlington, Massachusetts--(Newsfile Corp. - November 18, 2025) - Lifordi Immunotherapeutics, Inc., a clinical-stage biotech company developing antibody-drug conjugates (ADCs) for the treatment of aut
Lifordi Immunotherapeutics Secures Strategic Investment from Sanofi Ventures and Additional Capital from Existing Investors
12:00pm, Tuesday, 18'th Nov 2025
BURLINGTON, Mass.--(BUSINESS WIRE)-- #ADCs--Lifordi Immunotherapeutics, Inc., a clinical-stage biotech company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammato
Bank of New York Mellon Corp Sells 1,452,581 Shares of Sanofi $SNY
04:30am, Sunday, 16'th Nov 2025
Bank of New York Mellon Corp lowered its stake in Sanofi (NASDAQ: SNY) by 74.7% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund
Sanofi's type 1 diabetes drug recommended for EU approval
08:21am, Friday, 14'th Nov 2025
The European Medicines Agency's committee has recommended approval of French drugmaker Sanofi's first-of-its-kind drug that delays onset of the insulin-dependent stage 3 of type 1 diabetes, it said on
Press Release: Sanofi's Teizeild recommended for EU approval by the CHMP for patients with stage 2 type 1 diabetes
06:30am, Friday, 14'th Nov 2025
Sanofi's Teizeild recommended for EU approval by the CHMP for patients with stage 2 type 1 diabetes Recommendation based on the TN-10 study, demonstrating Teizeild's ability to delay the onset of stag
Traders Buy Large Volume of Put Options on Sanofi (NASDAQ:SNY)
01:10am, Wednesday, 12'th Nov 2025
Sanofi (NASDAQ: SNY - Get Free Report) saw unusually large options trading activity on Tuesday. Investors bought 30,724 put options on the stock. This represents an increase of approximately 1,171% co
The Zacks Analyst Blog Accenture, Sanofi and Dell
02:21am, Tuesday, 11'th Nov 2025
Chicago, IL – November 11, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting sto
